CAR-T Cell Therapy
CAR-TDrug Modalities
CAR-T (chimeric antigen receptor T-cell) therapy re-engineers a patient’s own T cells to recognize and attack cancer cells. It has produced durable responses in certain blood cancers but involves complex manufacturing and notable safety risks.
Related terms
Track CAR-T Cell Therapy across 1,000+ biotechs
BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.
Start Free